Index RUT
P/E 21.59
EPS (ttm) 5.08
Insider Own 1.08%
Shs Outstand 24.77M
Perf Week 2.34%
Market Cap 2.73B
Forward P/E 16.54
EPS next Y 6.62
Insider Trans -0.36%
Shs Float 24.60M
Perf Month 8.04%
Income 126.80M
PEG 2.88
EPS next Q 1.62
Inst Own 96.68%
Short Float / Ratio 0.57% / 1.87
Perf Quarter 4.69%
Sales 1.96B
P/S 1.39
EPS this Y -2.76%
Inst Trans -0.24%
Short Interest 0.14M
Perf Half Y 9.62%
Book/sh 45.26
P/B 2.42
EPS next Y 12.77%
ROA 7.71%
Target Price 124.50
Perf Year 0.54%
Cash/sh 8.33
P/C 13.15
EPS next 5Y 7.50%
ROE 11.45%
52W Range 91.74 - 116.00
Perf YTD 6.53%
Dividend 1.41
P/FCF 17.67
EPS past 5Y 16.10%
ROI 10.98%
52W High -5.53%
Beta 1.10
Dividend % 1.29%
Quick Ratio 1.55
Sales past 5Y 10.21%
Gross Margin 29.88%
52W Low 19.45%
ATR 2.19
Employees 2100
Current Ratio 2.51
Sales Q/Q -9.53%
Oper. Margin 8.35%
RSI (14) 65.54
Volatility 2.28% 1.99%
Optionable Yes
Debt/Eq 0.04
EPS Q/Q 1.12%
Profit Margin 6.45%
Rel Volume 0.84
Prev Close 110.63
Shortable Yes
LT Debt/Eq 0.03
Earnings Nov 07 AMC
Payout 24.04%
Avg Volume 74.35K
Price 109.58
Recom 2.00
SMA20 2.75%
SMA50 7.00%
SMA200 6.82%
Volume 62,476
Change -0.95%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-30-22 Initiated
Seaport Research Partners
Neutral
Sep-04-19 Initiated
CL King
Buy
$95
Apr-12-19 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Apr-24-18 Upgrade
Johnson Rice
Accumulate → Buy
Nov-14-17 Upgrade
Johnson Rice
Hold → Accumulate
Nov-09-17 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Aug-22-17 Upgrade
Monness Crespi & Hardt
Neutral → Buy
$65
Dec-19-16 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Nov-04-16 Reiterated
Monness Crespi & Hardt
Buy
$60 → $62
Aug-04-16 Upgrade
Monness Crespi & Hardt
Neutral → Buy
$60
Apr-05-16 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
Oct-12-15 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Feb-14-14 Reiterated
Monness Crespi & Hardt
Buy
$46 → $53
Feb-14-13 Reiterated
Monness Crespi & Hardt
Buy
$40 → $46
Nov-16-12 Initiated
KeyBanc Capital Mkts
Buy
$40
Nov-02-09 Downgrade
JP Morgan
Overweight → Neutral
Nov-16-07 Upgrade
JP Morgan
Neutral → Overweight
Jun-20-07 Downgrade
Matrix Research
Buy → Hold
Apr-20-07 Downgrade
Matrix Research
Buy → Hold
Show Previous Ratings
Nov-17-23 05:09AM
Nov-13-23 08:37AM
Nov-09-23 02:21PM
01:25AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:03PM
(Associated Press Finance)
04:45PM
Loading…
04:45PM
Oct-31-23 10:01AM
Oct-26-23 12:10PM
Oct-06-23 04:30PM
Sep-27-23 10:00AM
Aug-10-23 08:25AM
Aug-09-23 11:56PM
(Thomson Reuters StreetEvents)
Aug-08-23 07:15PM
06:13PM
(Associated Press Finance)
04:45PM
05:45PM
Loading…
Aug-02-23 05:45PM
Jul-19-23 07:34AM
Jul-13-23 02:56PM
Jul-06-23 04:45PM
Jul-02-23 10:47AM
Jun-29-23 09:13AM
08:42AM
Jun-21-23 08:00PM
Jun-20-23 06:19AM
Jun-18-23 09:48AM
Jun-01-23 08:10AM
May-29-23 07:09AM
May-14-23 08:15AM
May-07-23 08:04AM
May-03-23 07:05PM
06:06PM
Loading…
06:06PM
04:30PM
Apr-26-23 08:00PM
10:01AM
Apr-15-23 01:30PM
Apr-10-23 11:21AM
Apr-07-23 04:45PM
Mar-11-23 08:28AM
Mar-10-23 07:04AM
Feb-25-23 07:48AM
Feb-21-23 06:35PM
04:45PM
Feb-15-23 04:45PM
12:00PM
Feb-09-23 06:01AM
Jan-22-23 09:47AM
Jan-10-23 04:45PM
Jan-08-23 09:25AM
Dec-19-22 11:39AM
10:14AM
Dec-16-22 09:50AM
05:01AM
Dec-15-22 08:01AM
Dec-13-22 10:19AM
Dec-02-22 10:28AM
Dec-01-22 07:18AM
Nov-22-22 09:40AM
Nov-12-22 07:38AM
Nov-10-22 05:55AM
Nov-08-22 07:45PM
04:45PM
Nov-01-22 10:03AM
Oct-12-22 09:00AM
Oct-06-22 04:45PM
Sep-27-22 07:35AM
Sep-26-22 07:11AM
Sep-23-22 09:40AM
08:01AM
Sep-19-22 06:26AM
06:02AM
Sep-16-22 08:21AM
Sep-13-22 09:20AM
Sep-07-22 09:35AM
Sep-02-22 06:31AM
Aug-25-22 10:21AM
Aug-15-22 10:03AM
Aug-11-22 12:20PM
Aug-08-22 12:00PM
Aug-02-22 06:25PM
04:45PM
Aug-01-22 09:59AM
Jul-28-22 10:03AM
09:15AM
Jul-26-22 10:01AM
Jul-25-22 09:15AM
Jul-07-22 04:45PM
Jun-24-22 09:40AM
06:16AM
Jun-15-22 12:00PM
Jun-02-22 09:40AM
May-25-22 12:00PM
10:00AM
09:18AM
May-17-22 12:20PM
09:40AM
May-07-22 08:33AM
May-03-22 06:35PM
04:45PM
Apr-29-22 07:45AM
Apr-28-22 12:10PM
Innospec, Inc. develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customers' processes or products focused on the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations, chemical solutions for fracturing, stimulation and completion operations, and products for oil and gas production. The company was founded in 1938 and is headquartered in Englewood, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PADFIELD Larry Director Nov 13 Option Exercise 46.03 977 44,971 7,577 Nov 15 09:28 PM PADFIELD Larry Director Nov 13 Sale 101.54 977 99,208 6,600 Nov 15 09:28 PM PALLER Robert I Director Nov 10 Option Exercise 46.03 977 44,971 12,128 Nov 13 08:51 PM Poccia Claudia Director Aug 11 Option Exercise 70.74 424 29,994 1,533 Aug 14 09:33 PM Poccia Claudia Director May 22 Option Exercise 0.00 1,848 0 1,448 May 24 07:48 PM Poccia Claudia Director May 22 Sale 99.20 739 73,306 600 May 24 07:48 PM PADFIELD Larry Director May 12 Option Exercise 40.58 1,108 44,963 7,062 May 16 09:57 PM PARRETTE LESLIE J Director May 10 Buy 96.75 515 49,826 3,210 May 11 06:19 PM BARNES CORBIN SVP, Corporate Dev and IR Mar 17 Buy 99.75 400 39,900 1,847 Mar 20 08:43 PM BOON PHILIP JOHN Executive VP Business Ops Mar 07 Option Exercise 0.00 6,491 0 24,465 Mar 09 06:22 PM BARNES CORBIN SVP, Corporate Dev and IR Mar 07 Buy 106.00 1,250 132,500 1,447 Mar 09 06:31 PM BOON PHILIP JOHN Executive VP Business Ops Mar 07 Sale 105.62 6,491 685,552 18,748 Mar 09 06:22 PM Cleminson Ian VP & CFO Mar 06 Option Exercise 0.00 6,079 0 26,491 Mar 09 06:37 PM Cleminson Ian VP & CFO Mar 06 Sale 105.23 6,079 639,719 21,268 Mar 09 06:37 PM Williams Patrick PRESIDENT & CEO Mar 03 Option Exercise 0.00 3,967 0 161,337 Mar 09 06:26 PM PARRETTE LESLIE J Director Mar 03 Buy 111.35 450 50,108 1,044 Mar 06 06:54 PM Williams Patrick PRESIDENT & CEO Mar 03 Sale 109.18 11,439 1,248,942 138,458 Mar 09 06:26 PM Jones David B. SVP, GC & CCO Mar 02 Buy 108.98 459 50,022 6,534 Mar 02 01:19 PM Williams Patrick PRESIDENT & CEO Mar 02 Sale 108.93 11,440 1,246,125 149,897 Mar 09 06:26 PM Jones David B. SVP, GC & CCO Mar 01 Option Exercise 0.00 2,500 0 7,200 Mar 01 09:58 PM Williams Patrick PRESIDENT & CEO Mar 01 Sale 109.70 9,143 1,002,968 157,370 Mar 02 08:00 PM Williams Patrick PRESIDENT & CEO Feb 28 Sale 110.64 9,146 1,011,909 166,513 Mar 01 09:42 PM Williams Patrick PRESIDENT & CEO Feb 27 Sale 111.20 9,146 1,017,048 174,333 Mar 01 09:42 PM Williams Patrick PRESIDENT & CEO Feb 24 Option Exercise 95.70 1,323 126,611 184,802 Mar 01 09:42 PM Cleminson Ian VP & CFO Feb 24 Option Exercise 95.70 286 27,370 21,283 Mar 01 09:46 PM BOON PHILIP JOHN Executive VP Business Ops Feb 24 Option Exercise 95.70 258 24,691 18,774 Mar 01 09:49 PM Williams Patrick PRESIDENT & CEO Feb 24 Option Exercise 0.00 36,581 0 192,625 Feb 27 09:58 PM BOON PHILIP JOHN Executive VP Business Ops Feb 24 Option Exercise 0.00 2,263 0 19,580 Feb 27 09:54 PM LANDLESS DAVID Director Feb 24 Option Exercise 0.00 627 0 3,732 Feb 27 09:53 PM Jones David B. SVP, GC & CCO Feb 24 Option Exercise 0.00 3,937 0 4,898 Feb 27 09:50 PM Williams Patrick PRESIDENT & CEO Feb 24 Sale 108.50 9,146 992,329 183,479 Feb 27 09:58 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite